Primary Treatment for Hypogammaglobulinemia

Diagnostic Criteria and Treatment Algorithm

The American College of Allergy, Asthma, and Immunology recommends immunoglobulin replacement therapy for primary antibody deficiencies with IgG <400-500 mg/dL and recurrent infections, as indicated by the Journal of Allergy and Clinical Immunology 3
The guideline society suggests measuring IgG levels on at least two separate occasions, 1 month apart, to exclude transient decreases 2
Assessing functional antibody production by measuring specific antibody responses to pneumococcal vaccines is more predictive of infection risk than absolute IgG levels alone, according to Praxis Medical Insights 1, 2
Enumerating lymphocyte subsets by flow cytometry (CD19, CD4, CD8, memory B cells) helps characterize the immune defect 1, 2
Documenting infection history, including at least 2-3 severe recurrent bacterial infections per year, is essential for determining the need for immunoglobulin replacement therapy 1

The standard IVIG dosing is 0.2-0.4 g/kg body weight every 3-4 weeks, with a target trough IgG level of 600-800 mg/dL, as recommended by Praxis Medical Insights 1
For patients switching from IVIG to SCIG, the initial weekly SCIG dose is calculated based on the prior monthly IVIG dose, according to the Journal of Allergy and Clinical Immunology 3, 1

Regular monitoring of IgG trough levels every 6-12 months is essential for patients on immunoglobulin replacement therapy, as indicated by Praxis Medical Insights 1, 4
Patients with B-cell malignancies often benefit from IgG replacement when IgG <400-500 mg/dL with recurrent infections, according to Praxis Medical Insights 1
Patients on B-cell depleting therapies may require higher target IgG levels (650 mg/dL) and immunoglobulin supplementation for those with hypogammaglobulinemia and recurrent infections, as recommended by Praxis Medical Insights 1

Delaying IVIG during active infection is not recommended, as IVIG catabolism accelerates significantly during infections, according to Praxis Medical Insights 1
Fixed dosing without monitoring trough levels is not recommended, and individualized dosing based on IgG measurements and clinical response is suggested, as indicated by Praxis Medical Insights 1